These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32379504)

  • 1. What is the best clinical approach to recurrent/refractory osteosarcoma?
    Meazza C; Bastoni S; Scanagatta P
    Expert Rev Anticancer Ther; 2020 May; 20(5):415-428. PubMed ID: 32379504
    [No Abstract]   [Full Text] [Related]  

  • 2. Metastatic osteosarcoma: a challenging multidisciplinary treatment.
    Meazza C; Scanagatta P
    Expert Rev Anticancer Ther; 2016 May; 16(5):543-56. PubMed ID: 26999418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of management issues in relapsed osteosarcoma.
    Vijayamurugan N; Bakhshi S
    Expert Rev Anticancer Ther; 2014 Feb; 14(2):151-61. PubMed ID: 24308680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
    Ward WG; Mikaelian K; Dorey F; Mirra JM; Sassoon A; Holmes EC; Eilber FR; Eckardt JJ
    J Clin Oncol; 1994 Sep; 12(9):1849-58. PubMed ID: 8083708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future therapeutic approaches for osteosarcoma.
    Harrison DJ; Geller DS; Gill JD; Lewis VO; Gorlick R
    Expert Rev Anticancer Ther; 2018 Jan; 18(1):39-50. PubMed ID: 29210294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple relapses in high-grade osteosarcoma: when to stop aggressive therapy?
    Tamamyan G; Dominkus M; Lang S; Diakos C; Mittheisz E; Horcher E; Holter W; Zoubek A; Bielack S; Kager L
    Pediatr Blood Cancer; 2015 Mar; 62(3):529-30. PubMed ID: 25611048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
    Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
    Bielack SS; Kempf-Bielack B; Heise U; Schwenzer D; Winkler K
    J Clin Oncol; 1999 Apr; 17(4):1164. PubMed ID: 10561175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Treatment Considerations for Osteosarcoma Metastatic at Presentation.
    Tsukamoto S; Errani C; Angelini A; Mavrogenis AF
    Orthopedics; 2020 Sep; 43(5):e345-e358. PubMed ID: 32745218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
    Xu M; Xu S; Yu X
    World J Surg Oncol; 2014 Nov; 12():341. PubMed ID: 25391880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis.
    Tirtei E; Asaftei SD; Manicone R; Cesari M; Paioli A; Rocca M; Ferrari S; Fagioli F
    Tumori; 2018 Jun; 104(3):202-206. PubMed ID: 30086698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation, treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group.
    Mettmann VL; Baumhoer D; Bielack SS; Blattmann C; Friedel G; von Kalle T; Kager L; Kevric M; Nathrath M; Sorg B; Dürken M; Hecker-Nolting S
    Cancer Med; 2023 Sep; 12(17):18219-18234. PubMed ID: 37548393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival.
    Ferrari S; Briccoli A; Mercuri M; Bertoni F; Picci P; Tienghi A; Del Prever AB; Fagioli F; Comandone A; Bacci G
    J Clin Oncol; 2003 Feb; 21(4):710-5. PubMed ID: 12586810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study.
    Goorin AM; Shuster JJ; Baker A; Horowitz ME; Meyer WH; Link MP
    J Clin Oncol; 1991 Apr; 9(4):600-5. PubMed ID: 2066757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Rocca M; Ferrari S; Donati D; Longhi A; Bertoni F; Bacchini P; Giacomini S; Forni C; Manfrini M; Galletti S
    Ann Oncol; 2003 Jul; 14(7):1126-34. PubMed ID: 12853357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative therapy for osteosarcoma.
    Errani C; Longhi A; Rossi G; Rimondi E; Biazzo A; Toscano A; Alì N; Ruggieri P; Alberghini M; Picci P; Bacci G; Mercuri M
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):217-27. PubMed ID: 21342041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
    Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
    BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
    Benjamin R; Helman L; Meyers P; Reaman G
    Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.